VIENNA — A new draft consensus report from the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) updates the 2021 guidance on managing type 1 diabetes ...
Artificial pancreases took center stage at this year’s annual meeting of the American Diabetes Association, with Medtronic, Insulet and more touting clinical trial successes for components of their ...
As people with type 1 diabetes live longer than ever before, both clinicians and patients are recognizing the need to prepare ...
The Institute for Endocrinology and Diabetes, Schneider Children's Medical Center, Petah Tikva, and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Faculty of Medicine, University of ...
A Vertex Pharmaceuticals cell therapy for type 1 diabetes is enabling patients to produce insulin, eliminating the need for additional insulin therapy in the vast majority of participants in a key ...
Announcement of a podium presentation at a prestigious symposium, showcasing innovative research in cell therapy for type 1 diabetes. Presentation features promising clinical data on UP421, a novel ...
Though continuous glucose monitors have long been more widely used among people with Type 1 diabetes, new research has increasingly shown that the Type 2 population can majorly benefit from CGM use, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback